Insider Transactions Reported by 18 Insiders of Anika Therapeutics, Inc.

Symbol
ANIK on Nasdaq
Location
Bedford, MA

There are no Buy or Sell transactions made by insiders since 05 Jan 2025

Anika Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Cheryl R. Blanchard President, CEO, Director, Director $6,070,297 14 Mar 2025
Michael L. Levitz EVP, CFO, Treasurer $1,761,044 15 Mar 2024
David Colleran EVP, General Counsel, Corp Sec $1,467,047 14 Mar 2025
Stephen D. Griffin Evp, Cfo & Coo $1,404,907 03 Jun 2025
Anne Nunes SVP, Chief Operations Officer $725,770 14 Mar 2025
Thomas Finnerty EVP, Human Resources $589,713 09 Mar 2022
Jeffery S. Thompson Director $588,242 14 Jun 2023
Glenn R. Larsen Director $564,899 20 Jun 2025
SUSAN VOGT Director $564,394 20 Jun 2025
JOHN B. HENNEMAN III Director $560,550 20 Jun 2025
Stephen Richard Director $538,070 20 Jun 2025
SHERYL L. CONLEY Director $478,464 20 Jun 2025
Gary P. Fischetti Director $467,730 20 Jun 2025
William R. Jellison Director $259,677 20 Jun 2025
Ian McLeod VP, CAO and Treasurer $255,228 05 Apr 2025
Joseph H. Capper Director $229,329 20 Jun 2025
RAYMOND J. LAND Director $225,889 16 Jun 2021
James Loerop EVP Business Development $181,549 08 Jul 2021

Recent Insider Transactions by Companies or Individuals for Anika Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.